|
|
|
|
Vol. 10, Issue 11, 1796-1806, November 2000
METHODS
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
The endothelium plays a pivotal role in many physiological and pathological processes and is known to be an exceptionally active transcriptional site. To advance our understanding of endothelial cell biology and to elucidate potential pharmaceutical targets, we developed a new database screening approach to permit identification of novel endothelial-specific genes. The UniGene gene index was screened using high stringency BLAST against a pool of endothelial expressed sequence tags (ESTs) and a pool of nonendothelial ESTs constructed from cell-type-specific dbEST libraries. UniGene clusters with matches in the endothelial pool and no matches in the nonendothelial pool were selected. The UniGene/EST approach was then combined with serial analysis of gene expression (SAGE) library subtraction and reverse transcription polymerase chain reaction to further examine interesting clusters. Four novel genes were identified and labeled: endothelial cell-specific molecules (ECSM) 1-3 and magic roundabout (similar to the axon guidance protein roundabout). In summary, we present a powerful novel approach for comparative expression analysis combining two datamining strategies followed by experimental verification.
| |
INTRODUCTION |
|---|
|
|
|---|
In the postgenomic era, data analysis rather than data collection
will present the biggest challenge to biologists.
Efforts to ascribe biological meaning to genomic data, whether by
identification of function, structure, or expression pattern, are
lagging behind sequencing efforts (Boguski 1999
). Here, we describe the
use of two independent strategies for differential expression analysis combined with experimental verification to identify genes specifically or preferentially expressed in vascular endothelium.
The first strategy was based on an EST cluster expression analysis in
the human UniGene gene index (Schuler et al. 1997
). Recurrent gapped
BLAST searches (Altschul et al. 1997
) were performed at
very high stringency against expressed sequence tags (ESTs) grouped
into two pools. The two pools comprised endothelial cell and
nonendothelial cell libraries derived from dbEST (Boguski et al.
1995
). The second strategy used another datamining tool: SAGEmap
xProfiler. xProfiler is a freely available online tool, which is a part of the NCBI's Cancer Genome Anatomy Project (CGAP) (Cole et al. 1995
; Strausberg et al. 1997
).
These two approaches alone produced a discouragingly high number of false positives. However, when both strategies were combined, predictions proved exceptionally reliable and four novel candidate endothelial-specific genes have been identified. For two of these genes, full-length cDNAs have been identified in sequence databases. Another gene (EST cluster) corresponds to a partial cDNA sequence from a large-scale cDNA sequencing project and contains a region of similarity to the intracellular domain of human roundabout homolog 1 (ROBO1).
| |
RESULTS |
|---|
|
|
|---|
UniGene/EST Gene Index Screen
A pool of endothelial ESTs and a pool of nonendothelial ESTs were
extracted using the Sequence Retrieval System (SRS) from dbEST. The
endothelial pool consisted of 11,117 ESTs from nine human endothelial
libraries (Table 1). The nonendothelial
pool included 173,137 ESTs from 108 human cell lines and microdissected tumor libraries (Table 2).
ESTs were extracted from dbEST, release April 2000. Multiple-FASTA
files were transformed into BLAST searchable databases using the
pressdb program. Table 3 shows the
expression status of five known endothelial cell-specific genes in
these two pools: von Willebrand factor (vWF; Ginsburg et al.
1985
); two vascular endothelial growth factor receptors, fms-like
tyrosine kinase 1 (FLT1; Shibuya et al. 1990
) and kinase
insert domain receptor (KDR; Matthews et al. 1991
); tyrosine
kinase receptor type tie (TIE1; Partanen et al. 1992
); and
tyrosine kinase receptor type tek (TIE2/TEK; Vikkula et al.
1996
).
|
|
|
Optimizing the BLAST E-value was crucial for the success of BLAST
identity-level searches. Too high an E-value would result in gene
paralogs being reported. In contrast, too low (stringent) an
E-parameter would result in many false negatives, i.e., true positives
would not be reported because of sequencing errors in EST data; ESTs
are large-scale, low-cost single pass sequences and have a high error
rate (Aaronson et al. 1996
). In this work an E-value of 10e-20 was
used in searches against the nonendothelial EST pool and a more
stringent 10e-30 value was used in searches against the smaller
endothelial pool. These values were deemed optimal after a series of
test BLAST searches.
SAGE Data and SAGEmap xProfiler Differential Analysis
Internet-based SAGE library subtraction (SAGEmap
xProfiler) was used as the second datamining strategy
for the identification of novel endothelial-specific or preferentially
endothelial genes. Two endothelial SAGE libraries (SAGE_Duke_HMVEC and
SAGE_Duke_HMVEC + VEGF with a total of 110,790 sequences) were
compared with 24 nonendothelial cell line libraries (full list in Table
4, total of 733,461 sequences). Table
5 shows the status of expression of the
five reference endothelial-specific genes in these two SAGE pools.
|
|
Combined Data Gives Highly Accurate Predictions
Twenty known genes were selected in the UniGene/EST screen (Table
6). These genes had no matches in the
nonendothelial pool and at least one match in the endothelial pool. The
list contained four endothelial-specific genes: TIE1 (Partanen
et al. 1992
), TIE2/TEK (Vikkula et al. 1996
), LYVE1
(Banerji et al. 1999
), and multimerin (Hayward et al. 1998
),
indicating ~20% accuracy of prediction. Other genes on the list,
although certainly preferentially expressed in the endothelial cells,
may not be endothelial specific. To improve on the prediction accuracy,
we decided to combine UniGene/EST screen with the
xProfiler SAGE analysis. Table
7 shows how data from the two approaches
were combined. Identity-level BLAST searches were performed on mRNAs
(known genes) or phrap-computed contigs (EST clusters representing
novel genes) to investigate how these genes were represented in the
endothelial and nonendothelial pool. Subsequent experimental
verification by reverse transcription polymerase chain reaction
(RT-PCR; Fig. 1) proved that the combined approach was 100% accurate, i.e., genes on the xProfiler list that had no matches the nonendothelial EST pool and at least one
match in the endothelial pool were indeed endothelial specific.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
There have been several reports of computer analysis of tissue
transcriptosomes. Usually an expression profile is constructed, based
on the number of tags assigned to a given gene or a class of genes
(Bernstein et al. 1996
; Welle et al. 1999
; Bortoluzzi et al. 2000
). An
attempt can be made to identify tissue-specific transcripts: for
example, Vasmatzis et al. (1997)
described three novel genes expressed
exclusively in the prostate by in silico subtraction of libraries from
the dbEST collection. Purpose-made cDNA libraries may also be used. Ten
candidate granulocyte-specific genes have been identified by extensive
sequence analysis of cDNA libraries derived from granulocytes and
eleven other tissue samples, namely a hepatocyte cell line, fetal
liver, infant liver, adult liver, subcutaneous fat, visceral fat, lung,
colonic mucosa, keratinocytes, cornea, and retina (Itoh et al. 1998
).
An analysis similar to the dbEST-based approach taken by Vasmatzis et
al. (1997)
is complicated by the fact that endothelial cells are
present in all tissues of the body and endothelial ESTs are
contaminating all bulk tissue libraries. To validate this, we used
three well-known endothelial-specific genes
KDR,
FLT1, and TIE-2
as queries for BLAST searches
against dbEST. Transcripts were present in a wide range of tissues,
with multiple hits in well-vascularized tissues (e.g., placenta,
retina), embryonic tissues (liver, spleen), or infant tissues (brain).
In addition, we found that simple subtraction of endothelial EST
libraries against all other dbEST libraries failed to identify any
specific genes (data not shown).
Two very different types of expression data resources were used in our
datamining efforts. The UniGene/EST screen was based on EST libraries
from dbEST. There are nine human endothelial libraries in the current
release of dbEST, with a relatively small total number of ESTs
(11,117). Some well-known endothelial-specific genes are not
represented in this data set (Table 3). This limitation raised our
concerns that genes with low levels of expression would be overlooked
in our analysis. Therefore, we used another type of computable
expression data: CGAP SAGE libraries. SAGE tags are sometimes called
small ESTs (usually 10-11 bp in length). Their major advantage is that
they can be unambiguously located within the cDNA: they are immediately
adjacent to the most 3' NlaIII restriction site. Although there are
only two endothelial CGAP SAGE libraries available at the moment, they
contain an impressive total of ~111,000 tags
a data set
approximately ten times bigger than the 11,117 sequences in the
endothelial EST pool. The combined approach proved very accurate (Fig.
1; Table 8) when verified by RT-PCR. We report here identification of
four novel highly endothelial-specific genes: endothelial
cell-specific molecule 1 (ECSM1; UniGene entry Hs.13957),
endothelial cell-specific molecule 2 (ECSM2; UniGene entry
Hs.30089), endothelial cell-specific molecule 3 (ECSM3;
UniGene entry Hs.8135), and magic roundabout (UniGene entry
Hs.111518). For a comprehensive summary of data available on these
genes, see Table 8.
|
ECSM1 has no protein or nucleotide homologs. It codes for a small protein of ~103 aa, the longest and most upstream open reading frame (ORF) identified in the contig sequence.
BLAST searches against the EMBL patent database revealed that
ECSM2 corresponds to the cDNA from the patent "cDNA encoding novel polypeptide from human umbilical vein endothelial cell" (Shibayama et al. 1997
), EMBL acc. E10591. A 205-aa polypeptide coded
by this cDNA is a transmembrane protein with a suggested role in cell
adhesion in that it is serine and proline rich, although no exact
function has yet been identified.
ECSM3 was found to be identical with the matrix
remodeling-associated gene 4 (MXRA4, cDNA sequence acc.
AW888224) recently identified in a screen of 40,000 genes from 552 human cDNA libraries (M. Walker, pers. comm.). The strategy was based
on the assumption that coexpression implies similar function (guilt by
association). In total, eight novel genes coexpressed with 21 known
matrix remodelling-associated genes were identified. In the human
genome, ECSM3 is very closely associated with another
endothelial-specific gene, AA4 (Clq/MBL/SPA receptor, C1qRp,
Ly68). AA4 is a transmembrane protein expressed in vascular endothelial
cells, aortic hematopoietic clusters, and fetal liver hematopoietic
progenitors during fetal development, with a proposed role in the
development of vascular and hematopoietic systems, especially
cell-to-cell adhesion and/or signaling (Petrenko et al. 1999
). By
analyzing the 123,832-bp genomic clone AL118508, we found that
ECSM3 is an immediate genomic neighbor of AA4. Both genes were contained within the 8000-bp sequence: MXRA4 has
one exon, and AA4 has two exons and a small intron.
MXRA4 contains a 402-bp region of strong homology (64.4%
identity, E = 1.3e-24) to the 3' untranslated region (UTR) of
the mouse (and not human) AA4 mRNA (acc. AF081789). Such an
endothelial-specific gene cluster suggests existence of a functional
gene expression domain (for a review on expression domains, see Dillon
et al. 2000
). It is also possible that MXRA4 is a recent
evolutionary insertion into the AA4 locus, and it now
exploits a part of the AA4 regulatory sequence located in
the former 3'UTR of the AA4 gene. Because mouse
AA4 genomic structure is not available, it's impossible to
say whether a gene similar to MXRA4 is located in the
vicinity. BLAST search of the full-length MXRA4 cDNA against
the mouse EST database reveals only two similar ESTs that both belong
to the mouse AA4 transcript, suggesting that MXRA4 is
not present at all in the mouse genome.
BLAST searches for the Hs.111518 contig identified a cDNA clone
(GenBank acc. AK000805) with a long ORF of 417 (accession no. BAA
91382). This sequence is rich in prolines and has several regions of
low amino-acid complexity. BLAST PRODOM search (protein
families database at Human Genome Project Resource Centre) identified a
120-bp region of homology to the cytoplasmic domain conserved family of
transmembrane receptors involved in repulsive axon guidance (ROBO1
DUTT1 protein family; E = 4e-07). Homology was extended to 468 aa
(E = 1.3e-09) when a more rigorous analysis was performed using
ssearch (Smith and Waterman 1981
), but the region of
similarity was still restricted to the cytoplasmic domain. The ROBO1
DUTT1 family comprises the human roundabout homolog 1 (ROBO1), the
mouse gene DUTT1, and the rat ROBO1 (Kidd et al. 1998
, Brose et al.
1999
). Because of this region of homology, we called the gene
represented by Hs. 111518 magic roundabout. In addition,
BLAST SBASE (protein domain database at Human Genome
Project Resource Centre) suggested a region of similarity to the domain
of the intracellular neural cell adhesion molecule long domain form
precursor (E = 2e-11). It should be noted that the true protein
product for magic roundabout is likely to be larger than the
417 aa coded in the AK000805 clone because the ORF has no apparent
upstream limit, and size comparison to human roundabout 1 (1651 aa)
suggests a much bigger protein.
Recently, intriguing associations between neuronal differentiation
genes and endothelial cells have been discovered. For example, a
neuronal receptor for vascular endothelial growth factor (VEGF) neuropilin 1 (Soker et al. 1998
) was identified. VEGF was traditionally regarded as an exclusively endothelial growth factor. Processes similar
to neuronal axon guidance are now being implicated in guiding migration
of endothelial cells during angiogenic capillary sprouting. Thus,
ephrinB ligands and EphB receptors are involved in demarcation of
arterial and venous domains (Adams et al. 1999
). It is possible that
magic roundabout may be an endothelial-specific homolog of the human
roundabout 1 involved in endothelial-cell repulsive guidance,
presumably with a different ligand because similarity is contained
within the cytoplasmic (i.e., effector) region and guidance receptors
are known to have highly modular architecture (Bashaw and Goodman
1999
).
It should be noted that expression of endothelial-specific genes is not
usually 100% restricted to the endothelial cell. KDR and
FLT1 are both expressed in the male and female reproductive tract: on spermatogenic cells (Obermair et al. 1999
), on trophoblasts, and in decidua (Clark et al. 1996
). KDR has been shown to
define hematopoietic stem cells (Ziegler et al. 1999
). FLT1 is
also present on monocytes. In addition to endothelial cells,
vWF is strongly expressed in megakaryocytes (Nichols et al.
1985
; Sporn et al. 1985
) and, in consequence, is present on platelets.
Similarly, multimerin is present both in endothelial cells
(Hayward et al. 1993
) and platelets (Hayward et al. 1998
). Generally
speaking, endothelial and hematopoietic cells descend from same
embryonic precursors: hemangioblasts and many cellular markers are
shared between these two cell lineages (for review, see Suda et al.
2000
). A surprising result of our RT-PCR analysis was that the genes identified here (ECSM1-3 and magic roundabout)
appear to show greater endothelial specificity (Fig. 1) than does the
classic endothelial marker von Willebrand factor.
As stated before, vascular endothelium plays a central role in many
physiological and pathological processes and it is known to be an
exceptionally active transcriptional site. Approximately 1000 distinct
genes are expressed in an endothelial cell. In contrast, red blood
cells were found to express 8 separate genes, platelets to express 22, and smooth muscle to express 127 (Adams et al. 1995
). Known
endothelial-specific genes attract much attention from both basic
research and the clinical community. For example, endothelial-specific
tyrosine kinases
TIE1, TIE2/TEK, KDR, and FLT1
are crucial players in the regulation of vascular
integrity and angiogenesis (Sato et al. 1993
,1995
; Alello et al. 1995
;
Fong et al. 1995
; Shalaby et al. 1995
). Angiogenesis is now widely recognized as a rate-limiting process for the growth of solid tumors.
It is also implicated in the formation of atherosclerotic plaques and
restenosis. Finally endothelium plays a central role in the complex and
dynamic system regulating coagulation and hemostasis.
Our combined datamining approach, together with experimental verification, is a powerful functional genomics tool. This type of analysis can be applied to many cell types, not just endothelial cells. The challenge of identifying the function of discovered genes remains, but bioinformatics tools such as structural genomics or homology and motif searches can offer insights that can then be verified experimentally.
| |
METHODS |
|---|
|
|
|---|
Database Sequence Retrieval
Locally stored UniGene files (Build #111, release date May 2000) were used in the preparation of the final version of this paper. The UniGene Web site can be accessed at the http://www.ncbi.nlm.nih.gov/UniGene/. UniGene files can be downloaded from the ftp repository at ftp://ncbi.nlm.nih.gov/repository/unigene/. Representative sequences for the human subset of UniGene (the longest EST within the cluster) are stored in the file Hs.seq.uniq, whereas all ESTs belonging to the cluster are stored in a separate file called Hs.seq.
Sequences were extracted from the dbEST database accessed locally at the Human Genome Project Resource Centre using the SRS (SRS version 5) getz command. This was performed repeatedly using a PERL script for all the libraries in the endothelial and nonendothelial subsets, and sequences were merged into two multiple-FASTA files.
Selection Criteria for Nonendothelial EST Libraries
Selection of 108 nonendothelial dbEST libraries was largely manual. Initially, the list of all available dbEST libraries (http://www.ncbi.nlm.nih.gov/dbEST/libs_byorg.html) was searched using the keyword "cells" and the phrase "cell line". Although this search identified most of the libraries, additional keywords had to be added for the list to be full: "melanocyte," "macrophage," "HeLa," and "fibroblast." In some cases, the detailed library description was consulted to confirm that the library is derived from a cell line/primary culture. We also added a number of CGAP microdissected-tumor libraries. For that, Library Browser (available at http://www.ncbi.nlm.nih.gov/CGAP/hTGI/lbrow/cgaplb.cgi) was used to search for the keyword "microdissected."
UniGene Gene Index Screen
The UniGene gene transcript index was screened against the EST division of GenBank, dbEST. Both UniGene and dbEST were developed at the National Centre for Biotechnology Information (NCBI). UniGene is a collection of EST clusters corresponding to putative unique genes. It currently consists of four data sets: human, mouse, rat, and zebrafish. The human data set is comprised of approximately 90,000 clusters (UniGene Build #111, May 2000). By means of very high stringency BLAST identity searches, we aimed to identify those UniGene genes that have transcripts in the endothelial and not in the nonendothelial cell-type dbEST libraries. University of Washington BLAST2, which is a gapped version, was used as BLAST implementation. The E-value was set to 10e-20 in searches against the nonendothelial EST pool and to 10e-30 in searches against the smaller endothelial pool.
Although UniGene does not provide consensus sequences for its clusters, the longest sequence within the cluster is identified. Thus, this longest representative sequence (multiple-FASTA file Hs.seq.uniq) was searched using very high stringency BLAST against the endothelial and nonendothelial EST pool. If such representative sequence reported no matches, the rest of the sequences belonging to the cluster (UniGene multiple-FASTA file Hs.seq) followed as BLAST queries. Finally, clusters with no matches in the nonendothelial pool and at least one match in the endothelial pool were selected using PERL scripts analyzing BLAST textual output.
xProfiler SAGE Subtraction
xProfiler enables an online user to perform a
differential comparison of any combination of 47 SAGE libraries with a
total of ~2,300,000 SAGE tags using a dedicated statistical algorithm (Chen et al. 1998
). xProfiler can be accessed at
http://www.ncbi.nlm.nih.gov/SAGE/sagexpsetup.cgi. SAGE itself is a
quantitative expression technology in which genes are identified by
typically a 10- or 11-bp sequence tag adjacent to the cDNA's most
3' NlaIII restriction site (Velculescu et al. 1995
).
The two available endothelial cell libraries (SAGE_Duke_HMVEC and SAGE_Duke_HMVEC + VEGF) defined pool A, and 24 (see Table 4 for list) nonendothelial libraries together built pool B. The approach was verified by establishing the status of expression of the five reference endothelial-specific genes in the two SAGE pools (Table 5) using Gene to Tag Mapping (http://www.ncbi.nlm.nih.gov/SAGE/SAGEcid.cgi). Subsequently, xProfiler was used to select genes differentially expressed between the pools A and B. The xProfiler output consisted of a list of genes with a 10-fold difference in the number of tags in the endothelial compared with the nonendothelial pool sorted according to the certainty of prediction. A 90% certainty threshold was applied to this list.
The other CGAP online differential expression analysis tool, Digital
Differential Display (DDD), relies on EST expression data (source
library information) instead of using SAGE tags. We attempted to use
this tool similarly to SAGEmap xProfiler but have been
unable to obtain useful results. Five out of nine endothelial and 64 out of 108 nonendothelial cell libraries used in our BLAST-oriented
approach were available for online analysis using DDD
(http://www.ncbi.nlm.nih.gov/CGAP/info/ddd.cgi). When such analysis
was performed, the following were the 15 top scoring genes: annexin A2,
actin
1, ribosomal protein large P0, plasminogen activator
inhibitor type I, thymosin
4, peptidyloprolyl isomerase A,
ribosomal protein L13a, laminin receptor 1 (ribosomal protein SA),
eukaryotic translation elongation factor 1
1, vimentin, ferritin
heavy polypeptide, ribosomal protein L3, ribosomal protein S18,
ribosomal protein L19, and tumor protein translationally controlled 1. This list was rather surprising as it did not include any well-known
endothelial-specific genes, did not have any overlap with SAGE results
(Table 8), and contained many genes that in the literature are reported
to be ubiquitously expressed (i.e., ribosomal proteins, actin,
vimentin, ferritin). A major advantage of our UniGene/EST screen is
that instead of relying on source library data and fallible EST
clustering algorithms, it actually performs identity-level BLAST
comparisons in search of transcripts corresponding to a gene.
Mining Data on UniGene Clusters
To quickly access information about UniGene entries (e.g., literature references, sequence tagged sites, homologs, references to function), online resources were routinely used: NCBI's UniGene and LocusLink interfaces and Online Mendelian Inheritance in Man.
ESTs in UniGene clusters are not assembled into contigs, so before any sequence analysis, contigs were created using phrap assembler (for documentation on phrap, see http://bozeman.mbt.washington.edu/phrap.docs/phrap.html).
To analyze genomic contigs AC005795 (44,399 bp) and AL118508 (123,832 bp) containing ECSM1 and ECSM3, respectively, NIX Internet interface for multiapplication analysis of large unknown nucleotide sequences was used. For further information on NIX, see http://www.hgmp.mrc.ac.uk/NIX/. Alignments of ECSM1 and ECSM3 against AC005795 and AL118508 were obtained using the NCBI interface to the Human Genome: The NCBI Map Viewer. For further information on the NCBI Map Viewer, see http://www.ncbi.nlm.nih.gov/genome/guide/.
To search for possible transmembrane domains and signal sequences in
translated nucleotide sequences, three Internet-based applications were
used: DAS, http://www.biokemi.su.se/~server/DAS/ (Cserzo et al.
1997
); TopPred2, http://www.biokemi.su.se/~server/toppred2/ (Heijne
1992
); and SignalP, http://www.cbs.dtu.dk/services/SignalP/ (Nielsen et
al. 1997
).
Computing Resources
Computing resources of the Oxford University Bioinformatics Centre ( http://www.molbiol.ox.ac.uk) and the Human Genome Project Resource Centre (http://www.hgmp.mrc.ac.uk) were used.
Detailed information on PERL scripts used in this work, may be obtained from L.H. (lucash{at}icrf.icnet.uk).
Experimental Verification
To experimentally verify specificity of expression, we used RT-PCR. RNA was extracted from three endothelial and seven nonendothelial cell types cultured in vitro. Endothelial cultures were as follows: HMVEC (human microvascular endothelial cells), HUVEC (human umbilical vein endothelial cells) confluent culture, and HUVEC proliferating culture. Nonendothelial cultures were as follows: normal endometrial stromal (NES) cells grown in normoxia and NES grown in hypoxia, MDA 453 and MDA 468 breast carcinoma cell lines, HeLa, FEK4 fibroblasts cultured in normoxia and FEK4 fibroBLASTs cultured in hypoxia, SW480, and HCT116, the last two listed being colorectal epithelium cell lines.
If a sequence tagged site was available, dbSTS PCR primers were used
and cycle conditions suggested in the dbSTS entry followed. Otherwise,
primers were designed using the Primer3 program. Primers are listed in
Table 9.
|
Tissue Culture Media, RNA Extraction, and cDNA Synthesis
Cell lines were cultured in vitro according to standard tissue culture protocols. In particular, endothelial media were supplemented with endothelial-cell growth supplement (ECGS; Sigma) and heparin (Sigma) to promote growth. Total RNA was extracted using the RNeasy Minikit (Qiagen) and cDNA synthesized using the Reverse-IT 1st Strand Synthesis Kit (ABgene).
| |
ACKNOWLEDGMENTS |
|---|
We received extensive and patient help from many people in the British bioinformatics community, especially Drs. Sarah Butcher and John Peden from the Oxford University Bioinformatics Centre. We also thank Drs. Michael Göern and Ken Smith from the Imperial Cancer Research Fund laboratories for generous help with tissue culture techniques and preparation of RNA's for RT-PCR and Prof. Adrian Harris and Dr. Chris Norbury for stimulating discussions.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
FOOTNOTES |
|---|
1 Corresponding author.
E-MAIL bicknelr{at}icrf.icnet.uk; FAX 44 (0)-1865-222431.
Article and publication are at www.genome.org/cgi/doi/10.1101/gr.150700.
| |
REFERENCES |
|---|
|
|
|---|
a 3D model.
Nat. Genet.
21:
38-41[CrossRef][Medline].
-helices in prokaryotic membrane proteins: The dense alignment surface method.
Protein Eng.
6:
673-676.
-granules of resting platelets and is synthesized by a megakaryocytic cell line.
J. Clin. Invest.
91:
2630-2639.
cGMP-dependent protein kinase.
Hypertension
27:
552-557Received June 1, 2000; accepted in revised form August 29, 2000.
This article has been cited by other articles:
![]() |
E. Wallgard, E. Larsson, L. He, M. Hellstrom, A. Armulik, M. H. Nisancioglu, G. Genove, P. Lindahl, and C. Betsholtz Identification of a Core Set of 58 Gene Transcripts With Broad and Specific Expression in the Microvasculature Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1469 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-N. Rybak, C. Roesli, M. Kaspar, A. Villa, and D. Neri The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases Cancer Res., November 15, 2007; 67(22): 10948 - 10957. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Okada, K. Yano, E. Jin, N. Funahashi, M. Kitayama, T. Doi, K. Spokes, D. L. Beeler, S.-C. Shih, H. Okada, et al. A Three-Kilobase Fragment of the Human Robo4 Promoter Directs Cell Type-Specific Expression in Endothelium Circ. Res., June 22, 2007; 100(12): 1712 - 1722. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Jarvis and J. A. Nelson Human Cytomegalovirus Tropism for Endothelial Cells: Not All Endothelial Cells Are Created Equal J. Virol., March 1, 2007; 81(5): 2095 - 2101. [Full Text] [PDF] |
||||
![]() |
V. Castronovo, D. Waltregny, P. Kischel, C. Roesli, G. Elia, J.-N. Rybak, and D. Neri A Chemical Proteomics Approach for the Identification of Accessible Antigens Expressed in Human Kidney Cancer Mol. Cell. Proteomics, November 1, 2006; 5(11): 2083 - 2091. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fujiwara, M. Ghazizadeh, and O. Kawanami Potential role of the Slit/Robo signal pathway in angiogenesis Vascular Medicine, May 1, 2006; 11(2): 69 - 74. [Abstract] [PDF] |
||||
![]() |
C. J.M. Best, J. W. Gillespie, Y. Yi, G. V.R. Chandramouli, M. A. Perlmutter, Y. Gathright, H. S. Erickson, L. Georgevich, M. A. Tangrea, P. H. Duray, et al. Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy Clin. Cancer Res., October 1, 2005; 11(19): 6823 - 6834. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Korn, S. Rohrig, S. Schulze-Kremer, and U. Brinkmann Common denominator procedure: a novel approach to gene-expression data mining for identification of phenotype-specific genes Bioinformatics, June 1, 2005; 21(11): 2766 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Bedell, S.-Y. Yeo, K. W. Park, J. Chung, P. Seth, V. Shivalingappa, J. Zhao, T. Obara, V. P. Sukhatme, I. A. Drummond, et al. roundabout4 is essential for angiogenesis in vivo PNAS, May 3, 2005; 102(18): 6373 - 6378. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hendrickx, K. Doggen, E. O. Weinberg, P. Van Tongelen, P. Fransen, and G. W. De Keulenaer Molecular diversity of cardiac endothelial cells in vitro and in vivo Physiol Genomics, October 4, 2004; 19(2): 198 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Madden, B. P. Cook, M. Nacht, W. D. Weber, M. R. Callahan, Y. Jiang, M. R. Dufault, X. Zhang, W. Zhang, J. Walter-Yohrling, et al. Vascular Gene Expression in Nonneoplastic and Malignant Brain Am. J. Pathol., August 1, 2004; 165(2): 601 - 608. [Abstract] [Full Text] [PDF] |
||||